Official Twitter account for Pharmaceutical Executive, a digital and print magazine offering news and opinions, analysis, features and executive profiles.
🚨Our March issue is LIVE🚨
Learn about immunotherapy pioneer Mark Frohlich, MD, CEO of Indapta Therapeutics in our cover profile🔷 Sourcing, nurturing, and retaining talent🔷Making HCP analytics actually work for commercial teams🔷and much more right here➡️https://t.co/OhroSxYKFH
What makes social media worth your time?
Share your perspective and help shape the content you see on social media. Take the survey: https://t.co/qJGgDzNrkH
#IndustryScienceOne#SocialMediaStrategy
Are GLP-1s changing the pharma playbook?
Kevin Dondarski of Deloitte Consulting explains how GLP-1s becoming major value drivers signals a broader strategic shift for the industry.
Watch more: https://t.co/MczTPmlWKy
#Pharma#GLP1
What would a stronger FDA-biopharma relationship look like?
Harpreet Singh, MD, chief medical officer at Precision for Medicine and former FDA Oncology Division Director, shares her perspective.
👉Watch the full interview: https://t.co/wW9tLLzvWD
#FDA#Biopharma#PharmExec
Your SEO strategy may not be enough anymore.
AI search is now summarizing healthcare content into single answers, shaping patient and HCP perception instantly. When those answers are incomplete or misaligned, the risk isn’t just traffic loss it’s clinical, regulatory, and reputational impact.
In this upcoming webinar, learn how to:
✔ Understand how AI-generated answers are formed
✔ Strengthen content structure and evidence signals
✔ Improve accuracy and visibility in AI search results
✔ Track AI visibility beyond traditional metrics
Register here:https://t.co/o9ye3IGNnt
Cardinal Health is advancing biopharma logistics with integrated 3PL services, expanded cold chain capabilities, and faster speed-to-patient solutions designed for today’s complex supply chain demands. #PharmaLogistics
https://t.co/gA5XQGfy1B
🚨 PE Spotlight: Rewiring oncology operations at scale.
John Oyler of BeOne Medicines shares how the company is rethinking development speed, clinical execution, and global manufacturing strategy.
Explore the full feature: https://t.co/HZp2RcqTS7
#PharmExec#PEspotlight #Oncology #Pharma
Did you know?
The FDA has approved baxdrostat for uncontrolled hypertension, adding a new option for patients whose blood pressure remains difficult to manage on existing therapies.
🔗 Explore more: https://t.co/PfhUILs20s
#Pharma#FDA#Hypertension
A new all-oral treatment option for AML has entered the FDA-approved landscape.
The FDA approved Inqovi in combination with venetoclax as the first and only all-oral combination treatment regimen for certain patients with acute myeloid leukemia.
#Pharma#AML#FDA
Explore how ACTO is elevating sales effectiveness across life sciences—empowering over 50,000 field professionals to deliver confident, compliant HCP interactions. From global pharma leaders to emerging biotech, discover strategies driving field excellence: https://t.co/lM9Te1I4AT #LifeSciences
AI search is reshaping how healthcare brands get discovered.
Join Victoria Houston and Mark Traphagen to learn:
• How AI Overviews shape patient + HCP discovery
• Why brand content gets misrepresented in AI answers
• The SEO signals that influence what AI surfaces
• How to track and improve AI visibility at scale
Register here:https://t.co/URnYDtqzFw
Sustainability, safety, and precision are redefining pharma logistics—innovations in cold chain and last-mile delivery are ensuring therapies reach patients reliably and responsibly. #PharmaLogistics
https://t.co/k3AOLiJWcj
🚨 PE Spotlight: Bringing Hepatitis B innovation to scale in China
GSK teams up with SBP Group’s CTTQ unit to support Bepirovirsen’s launch across 5,000+ medical centers in mainland China.
🔗 Read more: https://t.co/GNSkZ6RsFC
#PharmExec#PESpotlight#HepatitisB#Biotech #DrugDevelopment
“The patient is at the heart of everything we do.”
Jessica Lovett, VP of commercial strategy and innovation at Innomar, discusses the core principle she keeps in mind when developing strategies.
Watch the video below and explore more shorts here:https://t.co/XBxV9N6U3P
#PharmExec #PatientCare #HealthcareInnovation #PharmaIndustry #CommercialStrategy
Why does the US healthcare system feel so disconnected?
Will Shrank breaks down how fragmentation across payers, providers, and patients is driving inefficiencies and rising costs.
Watch the below to hear more.
#PharmExec#Healthcare#TrendingPharma
We recently welcomed Jesse Mendelsohn (SVP, Model N) to MJH Studios 🎙️
He joined Mike Christel to break down the complex relationship between PBMs and manufacturers in our Pricing & Policy series.
Check out our debut episode: https://t.co/TGy9ShIT11 Episode 2 coming soon 👀
#PharmExec #Pharma #HealthcarePolicy #PBM
In this short, Jeff Golfman, founder and president of Send 123, explains why moving away from just-in-time models can strengthen supply chain resilience, reduce risk exposure, and improve operational stability.
📺 Watch the clip below!
#PharmExec#SupplyChain#Logistics
Legacy patient support models are driving delays and drop-offs—automation and integrated workflows can reduce friction, speed time to therapy, and improve conversion. #PatientAccess
https://t.co/dY3OxsqBwH
🚨 PE Spotlight: How does the Strait of Hormuz factor into pharmaceutical risk?
Geralyn Ritter and Monica Gorman examine how this critical passage connects to pharmaceutical supply chains and the movement of key materials.
🔗 See how the Strait of Hormuz is influencing pharma: https://t.co/3is7mzomsO
#TrendingPharma #SupplyChain #RiskManagement #Geopolitics
Innovation is driven by people & great work deserves recognition.
🚨 Last call: Nominate a rising leader for the Emerging Pharma Leaders Awards (sponsored by BGB Group) before May 1st: https://t.co/y2hENmctYF
Thank you to all who’ve submitted! We’re excited to select our winners!
#PharmExec #EmergingPharmaLeaders #Innovation #Leadership